iHeart

Dr. Jess Goodman of Toronto and Sarah Goodman of Vancouver, BC asked for $500,000 for 20% of iHeart, a bluetooth fingertip device and mobile app that measures aortic stiffness to determine a user's internal age as a proxy for overall health, with results in about 30 seconds. The device retails online for about $200 and comes with a free consumer app, along with a newly developed professional model priced at $20 with a $9.99 monthly recurring subscription aimed at personal trainers, nutritionists, naturopaths, physicians, and corporate wellness clients. Following an Indiegogo campaign about a year prior, the company shipped its first 400 devices and has done over $180,000 in sales with no marketing spend, while Dr. Jess Goodman has personally invested over $1 million into the venture.

Manjit Minhas went out over the valuation relative to traction. Michele Romanow offered $500,000 for 20%, Michael Wekerle offered $500,000 for 20% while also trying to bring in Jim Treliving, and Jim Treliving offered $500,000 for 25%; Michael Wekerle then raised his offer to $1,000,000 for 30% with a 5% royalty until repaid. The founders ultimately chose to go with Michele Romanow's offer.

iHeart is still operating and sells through its website.